Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Epigenome analysis of newborn placenta and cord blood samples

ABSTRACT: DNA methylation profiling of placenta and cord blood samples. The Illumina GoldenGate methylation assay was used to obtain DNA methylation profiles across approximately 1,536 CpGs in 23 placenta and 23 cord blood samples.

ORGANISM(S): Homo sapiens

PROVIDER: GSE36852 | GEO | 2012/03/29

SECONDARY ACCESSION(S): PRJNA157197

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Epigenome analysis of newborn placenta and cord blood samples

Project description:DNA methylation profiling of placenta and cord blood samples. The Illumina GoldenGate methylation assay was used to obtain DNA methylation profiles across approximately 1,536 CpGs in 23 placenta and 23 cord blood samples. Bisulphite converted DNA from the 46 samples were hybridised to the Illumina GoldenGate Methylation assay

2012-03-28 | E-GEOD-36852 | biostudies-arrayexpress

Epigenome analysis of placenta/cord blood/saliva samples

Project description:Genome wide DNA methylation profiling of placenta/cord blood/saliva samples obtained from babies born by oocyte in vitro maturation (IVM) or in vitro fertilization (IVF). The Illumina Infinium EPIC Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across approximately 850,000 CpGs. The main goal of this project was to find specific methylation profiles associated to use of IVM.

2023-07-20 | GSE208704 | GEO

Methylation analysis of cancer and control samples.

2012-11-01 | GSE33614 | GEO

Epigenome analysis of placenta samples from newborns

2012-03-29 | GSE36829 | GEO

Exposure to Gestational Diabetes Mellitus In Utero Alters DNA Methylation in Placenta and Fetal Cord Blood [Placenta]

Project description:Genome wide DNA Methylation in fetal cord blood and placenta from mother with GDM compared to mother with normal glucose tolerance

2021-01-31 | GSE153220 | GEO

Reduced representation bisulfite sequencing (RRBS) methylation profiles of placenta and umbilical cord blood with or without gestational diabetes mellitus (GDM)

Project description:Objective: To explore the characteristics and underlying molecular mechanisms of genome-scale expression profiles of women with- or without- gestational diabetes mellitus and their offspring. Materials and Methods: We recruited a group of 21 pregnant women with gestational diabetes mellitus (GDM) and 20 healthy pregnant women as controls. For each pregnant women, RRBS were performed using the placenta and paired neonatal umbilical cord blood specimens. Differentially methylated regions (DMRs) were identified. Then, functional enrichment analysis was performed to differential methylated genes (DMGs) separately or interactively in placenta and umbilical cord blood. Results: Through the comparison of GDM and healthy samples, 2779 and 141 DMRs were identified from placenta and umbilical cord blood, respectively. Functional enrichment analysis showed that the placenta methylation and expression profiles of GDM women mirrored the molecular characteristics of “type II diabetes” and “insulin resistance”. Methylation-altered genes in umbilical cord blood were associated with pathways “type II diabetes” and “cholesterol metabolism”. DMGs illustrated significant overlaps among placenta and umbilical cord blood samples, and the overlapping DMGs were associated with cholesterol metabolism. Conclusions: Our research demonstrated the epigenomic alternations of GDM mothers and offspring. Our findings emphasized the importance of epigenetic modifications in the communication between pregnant women with GDM and offspring, and provided reference for the prevention, control, treatment, and intervention of perinatal deleterious events of GDM and neonatal complications.

2022-05-31 | GSE203169 | GEO

Methylation analysis of cancer and control samples.

Project description:DNA methylation profiling of cancer and control samples. The Illumina GoldenGate Methylation Cancer Panel I was used to obtain DNA methylation profiles across 1,505 CpG sites CpGs distributed across 807 genes in blood DNA specimens. DNA samples were extracted from blood specimens, bisulfite treated and subsequently used for GoldenGate Methylation Cancer Panel I Array (Illumina) according to manufacturer’s protocol together with normalization methylated, hemimethylated and unmethylated DNA controls (Qiagen).

2012-11-01 | E-GEOD-33614 | biostudies-arrayexpress

Genome-wide analysis of gene expression levels in placenta and cord blood samples from newborns babies

Project description:Genome wide expression profiling of placenta and cord blood samples from 48 newborns. Total RNA obtained from placenta and cord blood samples from 48 newborns.

2012-03-28 | E-GEOD-36828 | biostudies-arrayexpress

Epigenome analysis of placenta samples from newborns

Project description:Genome wide DNA methylation profiling of placenta samples from 48 newborns. The Illumina Infinium 27k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across approximately 27,000 CpGs. Bisulphite converted DNA from the 48 samples were hybridised to the Illumina Infinium 27k Human Methylation Beadchip v1.2

2012-03-28 | E-GEOD-36829 | biostudies-arrayexpress

Genome-wide analysis of gene expression levels in placenta and cord blood samples from newborns babies

Project description:Genome wide expression profiling of placenta and cord blood samples from 48 newborns.

2012-03-29 | GSE36828 | GEO